Abvc Biopharma (ABVC) Minority Interest (2018 - 2026)
Abvc Biopharma's (ABVC) quarterly Minority Interest came in at $2.1 million in Q1 2026, down 19.44% YoY from $2.6 million in Q1 2025, and down 5.93% on a QoQ basis from $2.2 million in Q4 2025.
Abvc Biopharma (ABVC) Minority Interest (2018 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 9 years of Minority Interest data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Minority Interest fell 19.44% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 19.44% YoY) and the FY2025 annual result came in at $2.2 million, up 535.23% from the prior year.
- Minority Interest retreated to $2.1 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $2.6 million in Q1 2025 to a low of -$502181.0 in Q4 2024.
- A 5-year average of $578842.6 and a median of -$38259.0 in 2023 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2024 — Minority Interest plunged 2100.46% — and 2025, when it soared 1158.53%.
- Tracing ABVC's Minority Interest over 5 years: stood at $137554.0 in 2022, then sank by 318.56% to -$300637.0 in 2023, then plunged by 67.04% to -$502181.0 in 2024, then soared by 535.23% to $2.2 million in 2025, then dropped by 5.93% to $2.1 million in 2026.
- The last three Minority Interest figures came in at $2.1 million (Q1 2026), $2.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | -502,181.00 |
| Sep 30, 2024 | -305,087.00 |
| Jun 30, 2024 | -246,157.00 |
| Mar 31, 2024 | -241,081.00 |
| Dec 31, 2023 | -300,637.00 |
| Sep 30, 2023 | -38,259.00 |
| Jun 30, 2023 | 12,305.00 |
| Mar 31, 2023 | 64,019.00 |
| Dec 31, 2022 | 137,554.00 |
| Sep 30, 2022 | -225,482.00 |
| Jun 30, 2022 | -153,822.00 |
| Mar 31, 2022 | -65,486.00 |
| Dec 31, 2021 | 26,689.00 |
| Sep 30, 2021 | -1.00 Mn |